amyloid
fibril
format
long
studi
varieti
protein
capabl
adopt
structur
despit
share
littl
sequenc
homolog
make
amyloid
fibril
challeng
focu
inhibit
studi
peptid
protein
form
amyloid
fibril
target
base
sequenc
motif
peptid
inhibitor
target
specif
amyloidogen
protein
reli
heavili
sequenc
recognit
ensur
inhibitori
peptid
abl
bind
target
approach
limit
target
one
amyloidogen
protein
time
howev
increas
evid
crossreact
amyloidform
polypeptid
therefor
becom
use
studi
similar
protein
goe
beyond
sequenc
homolog
inde
observ
amyloidogen
protein
adopt
similar
secondari
structur
along
pathway
fibril
format
open
way
interest
investig
develop
inhibitor
could
univers
amyloid
trap
review
analyz
two
specif
amyloidogen
protein
human
amylin
introduc
small
number
peptid
shown
capabl
inhibit
amyloidogenesi
dissimilar
polypeptid
inhibitori
peptid
motif
may
inde
applic
amyloidogen
system
amyloidogen
protein
typic
protein
tend
misfold
nativ
state
form
conform
undergo
selfselfassoci
result
solubl
oligom
oligomeris
creat
protofibril
follow
matur
amyloid
fibril
insolubl
view
plaqu
fig
amyloid
fibril
character
long
unbranch
fibril
made
strand
well
order
geometri
run
perpendicular
long
axi
fibril
amyloidform
protein
link
differ
diseas
includ
alzheim
diseas
parkinson
diseas
type
ii
diabet
huntington
diseas
diseas
said
caus
differ
protein
form
amyloid
deposit
similar
morpholog
regardless
sequenc
past
amyloid
plaqu
accept
caus
diseas
howev
mount
evid
toxic
form
amyloidogen
peptid
occur
much
earlier
solubl
oligom
discoveri
support
observ
amount
amyloid
plaqu
found
patient
amyloid
diseas
correl
sever
diseas
review
focus
two
wellknown
amyloidogen
protein
alphasynuclein
protein
implic
develop
parkinson
diseas
human
amylin
ham
protein
implic
develop
type
ii
diabet
also
examin
peptid
inhibitor
develop
reduc
toxic
polypeptid
tabl
inhibitor
may
point
common
thread
connect
misfold
pathway
protein
first
link
parkinson
alphasynuclein
amino
acid
peptid
found
predominantli
neural
tissu
initi
assum
involv
alzheim
diseas
protein
later
link
parkinson
due
missens
mutat
italian
famili
hereditari
parkinson
diseas
unfortun
exact
function
protein
well
understood
sever
possibl
role
posit
includ
one
dopamin
homeostasi
anoth
assembl
solubl
nsf
attach
protein
receptor
associ
synapt
vesicl
shown
stabil
vesicl
inhibit
neurotransmitt
releas
misfold
protein
implic
death
dopamin
produc
cell
result
develop
parkinson
diseas
alphasynuclein
sequenc
divid
three
region
ntermin
region
consist
residu
nac
region
consist
residu
ctermin
tail
consist
residu
fig
nativ
form
exist
random
coil
protein
adopt
configur
contact
lipid
conform
chang
replic
vitro
presenc
membran
membranelik
environ
howev
also
capabl
misfold
form
amyloid
plaqu
vilar
et
al
put
forth
structur
amyloid
state
structur
deriv
quench
deuteriumhydrogen
exchang
nmr
propos
adopt
five
distinct
residu
strand
connect
short
unstructur
loop
fig
sinc
new
cryoem
studi
suggest
capabl
adopt
investig
protofila
structur
adopt
propos
truncat
form
form
distinct
broken
glycin
residu
li
et
al
hand
use
cryoem
studi
protofila
state
full
length
result
indic
protofila
adopt
distinct
third
studi
done
jiang
cowork
argu
protofila
polymorph
therefor
capabl
form
differ
structur
studi
abl
identifi
two
polymorph
larg
quantiti
rod
twister
polymorph
form
fulllength
misfold
tradit
assum
origin
nac
region
protein
sinc
region
contain
minimum
sequenc
amino
acid
capabl
undergo
amyloidogenesi
howev
new
studi
show
may
earlier
event
occur
amyloidogenesi
nac
region
mirecka
et
al
propos
seri
residu
within
ntermin
region
peptid
may
play
nucleat
role
amyloidogenesi
region
residu
fig
identifi
first
two
amyloid
structur
propos
vilar
et
al
also
demonstr
residu
locat
region
first
residu
display
peak
attenu
solut
nmr
amyloid
induc
condit
point
possibl
initi
amyloid
event
occur
region
salveson
et
al
show
hairpin
region
capabl
form
higher
order
structur
display
high
level
toxic
neuron
cell
support
hypothesi
solubl
oligom
conform
amyloidogen
peptid
toxic
latest
cryoem
studi
protofila
state
also
pinpoint
region
interfac
protofila
dimer
final
import
region
within
seen
point
mutat
within
snca
gene
link
autosom
domin
form
parkinson
diseas
mutat
except
one
occur
region
mutat
shown
increas
rate
amyloidogenesi
vitro
provid
support
region
may
nucleat
amyloidogenesi
ctermin
region
also
interest
known
compact
random
coil
protein
similar
size
attribut
long
rang
interact
ctermin
tail
residu
within
nac
region
ntermin
region
interact
may
exert
protect
effect
prevent
aggreg
sinc
truncat
region
result
higher
rate
amyloid
format
also
shown
region
remain
unstructur
solubl
oligom
phase
amyloidogenesi
parkinson
diseas
therapi
reli
treat
symptom
diseas
rather
caus
studi
inhibitor
capabl
prevent
amyloidogenesi
abrog
toxic
caus
misfold
also
report
inhibitor
typic
act
one
four
way
prevent
misfold
protein
stabil
nativ
state
increas
rate
amyloid
format
protein
spend
littl
time
toxic
solubl
oligom
phase
redirect
amyloidogenesi
earli
stage
form
nontox
aggreg
final
promot
clearanc
toxic
form
protein
small
molecul
success
inhibitor
andor
pd
share
common
motif
presenc
phenol
moieti
resveratrol
small
molecul
found
skin
grape
berri
polyphenol
tabl
small
molecul
shown
antioxid
properti
well
abil
confer
neuroprotect
effect
rat
induc
parkinson
diseas
studi
done
jin
et
al
show
administ
resveratrol
result
neuroprotect
test
subject
littl
h
howev
mechan
resveratrol
neuroprotect
may
involv
direct
interact
vitro
studi
show
resveratrol
modest
effect
amyloidogenesi
instead
action
resveratrol
attribut
activ
human
sirtuin
sirt
shown
promot
autophagi
protein
nucleu
cytoplasm
anoth
well
studi
small
molecul
inhibit
gallic
acid
vitro
studi
shown
small
molecul
capabl
reduc
amount
toxic
oligom
form
high
dose
gallic
acid
reduc
format
toxic
nontox
oligom
lower
dose
gallic
acid
less
effect
prevent
oligomeris
howev
oligom
determin
nontox
neuron
cell
fact
conclud
gallic
acid
redirect
amyloidogenesi
form
offpathway
nontox
aggreg
studi
show
gallic
acid
may
bind
intermedi
conform
stabil
size
exclus
chromatographi
show
offpathway
oligom
form
incub
gallic
acid
contain
gallic
acid
indic
strong
interact
two
molecul
gallic
acid
also
part
deriv
known
epigallocatechin
gallat
egcg
tabl
wellknown
inhibitor
amyloidogenesi
found
green
tea
egcg
shown
inhibit
amyloidogen
protein
amyloidbeta
tau
implic
alzheim
diseas
incub
egcg
shown
redirect
amyloid
format
offpathway
nontox
aggreg
propos
mechan
protect
bind
egcg
ctermin
tail
monomer
separ
studi
show
bind
may
specif
ctermin
tail
could
fact
occur
throughout
sequenc
also
studi
propos
bind
occur
oligomer
state
protein
destabil
thu
offer
protect
cytotox
efficaci
polyphenol
inhibitor
propos
link
abil
molecul
form
quinon
quinon
propos
interact
aromat
residu
within
prevent
stack
residu
selfselfinteract
hypothesi
support
fact
molecul
shown
interact
ctermin
tail
three
protein
four
tyrosin
residu
locat
small
molecul
shown
interest
result
vitro
main
problem
therapi
remain
inabl
molecul
cross
bloodbrain
barrier
howev
recent
studi
emerg
show
known
antidepress
nortriptylin
tabl
possibl
inhibitor
vitro
studi
done
collier
et
al
show
dosedepend
decreas
aggreg
presenc
studi
done
transgen
drosophila
show
progress
retin
degener
express
absenc
significantli
attenu
fli
fed
food
supplement
studi
also
includ
experi
done
transgen
mice
mice
given
intraperiton
inject
accumul
cortex
hippocampu
analyz
analysi
show
inhibit
progress
amyloid
format
dose
relat
fashion
author
propos
mechan
neuroprotect
confer
aris
interact
monom
result
show
presenc
monomer
solvent
access
therefor
less
prone
form
oligom
apart
small
molecul
peptid
also
shown
reduc
effect
cytotox
exampl
one
categori
peptid
known
affitop
tabl
design
mimic
structur
solubl
oligom
form
ctermin
sequenc
gener
immun
respons
lack
sequenc
similar
affitop
nativ
prevent
develop
deadli
immun
respons
specif
target
toxic
form
protein
success
mous
model
studi
led
vaccin
test
clinic
trial
preliminari
result
show
vaccin
effect
reduc
worsen
parkinson
diseas
symptom
howev
drop
antibodi
level
time
prompt
need
booster
dose
ttr
link
hot
segment
ham
vaccin
attract
approach
parkinson
diseas
therapi
common
approach
peptid
inhibitor
design
inhibit
transit
monomer
oligomer
form
preval
approach
design
identifi
isol
region
prone
aggreg
modifi
region
solubl
less
abl
selfassoci
one
method
prevent
continu
selfselfassoci
nmethyl
residu
within
isol
region
substitut
prolin
residu
prevent
selfassoci
face
peptid
elimin
abil
form
stabl
hydrogen
bond
thu
prevent
format
intermolecular
sequenc
homolog
modifi
peptid
allow
recognit
lack
primari
nitrogen
opposit
face
peptid
prevent
amyloidogenesi
exampl
one
peptid
gavvtg
vtava
addit
nmethyl
prevent
aggreg
peptid
vitro
importantli
peptid
capabl
reduc
toxic
full
length
human
amylin
first
amyloidogen
peptid
discov
eugen
l
opi
attribut
degener
islet
cell
diabet
patient
amyloid
plaqu
westermark
final
abl
identifi
amino
acid
peptid
made
fibril
amyloid
plaqu
first
seen
opi
nt
year
later
accur
character
ham
done
cooper
et
al
studi
show
ham
disulfid
bond
two
cystein
residu
nterminu
amid
cterminu
fig
studi
show
peptid
nativ
random
coil
helix
favor
nterminu
residu
middl
section
capabl
independ
form
aggreg
ctermin
tail
adopt
random
coil
structur
solut
unlik
function
ham
bodi
better
understood
ham
releas
pancrea
respons
signal
trigger
releas
insulin
caus
protein
cosecret
ratio
believ
ham
function
tandem
insulin
prevent
releas
glucagon
decreas
gastric
empti
stimul
satieti
center
brain
ham
misfold
becom
toxic
origin
possibl
caus
channel
pore
format
lipid
bilay
channel
promot
influx
calcium
ion
efflux
potassium
sodium
ion
possibl
mechan
ham
toxic
gener
reactiv
oxygen
speci
trigger
apoptosi
promot
express
gene
link
cell
apoptosi
cjun
fasassoci
death
domain
misfold
ham
proce
similar
sequenc
event
amyloidogen
protein
howev
recent
studi
posit
possibl
helic
intermedi
adopt
ham
transit
conform
typic
seen
amyloidogen
pathway
variou
spectroscop
studi
detect
increas
charact
ham
prior
format
crystal
structur
analysi
ham
fuse
maltosebind
protein
mbp
indic
ntermin
helix
ham
capabl
form
strong
aromat
stack
residu
two
ham
monom
mutat
improv
helic
propens
residu
result
increas
rate
amyloidogenesi
residu
favor
format
decreas
rate
aggreg
evid
helic
intermedi
found
increas
propens
ham
aggreg
presenc
lipid
membran
shown
promot
format
helic
ntermin
half
ham
howev
transit
helix
play
even
import
role
amyloidogenesi
ham
upon
strongli
helixfavor
solvent
condit
ham
show
sign
amyloidogenesi
type
overstabil
ham
secondari
state
propos
mechan
insulin
prevent
aggreg
ham
healthi
individu
also
link
way
rat
amylin
abl
prevent
cytotox
ham
observ
mutant
rat
amylin
form
less
stabl
unabl
inhibit
ham
level
wild
type
rat
amylin
shift
equilibrium
conform
favor
state
also
shown
decreas
rate
fibril
format
anoth
amyloid
form
protein
howev
presenc
three
prolin
versu
ham
ram
may
signific
featur
studi
maintain
ham
solubl
major
area
investig
late
shown
use
prolin
key
posit
ham
abl
maintain
solubl
protein
minim
effect
activ
ham
discoveri
import
allow
synthesi
solubl
protein
known
pramlintid
could
serv
accompani
insulin
therapi
patient
type
type
ii
diabet
recent
studi
therapeut
effect
pramlintid
discov
possibl
use
peptid
potenti
therapi
combat
obes
among
other
ravussin
et
al
show
patient
administ
pramlintid
accompani
leptinanalogu
metreleptin
demonstr
signific
weight
loss
ham
inhibitor
typic
fallen
two
categori
small
molecul
peptid
tabl
interestingli
small
molecul
known
inhibitor
aggreg
also
shown
effect
ham
exampl
resveratrol
shown
inhibit
ham
amyloid
format
dose
depend
manner
studi
done
jiang
et
al
suggest
resveratrol
inhibit
ham
aggreg
disrupt
aromat
stack
ham
monom
residu
fig
particular
found
import
sinc
mutat
residu
leucin
decreas
ham
amyloidogen
result
decreas
resveratrol
activ
anoth
small
molecul
inhibit
ham
baicalein
tabl
small
molecul
flavonoid
found
root
certain
flower
plant
studi
show
baicalein
capabl
inhibit
ham
aggreg
dosedepend
manner
action
molecul
depend
presenc
least
two
hydroxyl
group
one
posit
benzen
ring
quinon
intermedi
propos
part
mechan
action
baicalein
ham
similar
propos
phenol
molecul
recent
howev
new
small
molecul
shown
inhibit
ham
amyloidogenesi
well
decreas
toxic
relat
ham
aggreg
montan
et
al
demonstr
pba
tabl
drug
current
use
treat
ureacycl
disord
cystic
fibrosi
capabl
restor
glucos
metabol
transgen
mice
overexpress
ham
test
show
pba
abl
restor
function
prevent
death
transgen
mice
vitro
experi
confirm
pba
interact
ham
show
decreas
ham
amyloidogenesi
dosedepend
manner
ham
also
shown
inhibit
peptid
common
motif
employ
design
peptid
inhibitor
ham
mutat
key
residu
prolin
one
mutat
result
peptid
undergo
aggreg
abl
increas
lag
time
ham
aggreg
coincub
ham
equimolar
concentr
like
anoth
frequent
employ
techniqu
isol
amyloidpron
sequenc
within
ham
develop
analog
peptid
contain
nmethyl
residu
ham
region
residu
well
studi
fig
nmethyl
residu
shown
result
peptid
nonaggregatori
nontox
abl
inhibit
full
length
nativ
ham
incub
fold
excess
ham
studi
target
similar
region
within
ham
solubl
hexapeptid
deriv
region
ham
found
strong
inhibitor
ham
aggreg
note
region
focus
studi
propos
sever
studi
adopt
conform
final
fibril
state
ham
luca
et
al
propos
final
fibril
form
ham
adopt
two
connect
loop
consist
residu
fig
wiltziu
et
al
support
propos
studi
crystal
structur
two
fragment
ham
studi
residu
sstnvg
found
adopt
steric
zipper
residu
nnfgail
found
adopt
loop
structur
shim
et
al
propos
format
two
independ
one
anoth
format
loop
residu
nucleat
event
theori
strengthen
studi
done
sivanesam
et
al
show
age
sampl
nfgailss
effect
inhibitor
aggreg
full
length
ham
one
possibl
explan
observ
presum
inhibitor
lock
region
ham
conform
prevent
transit
requir
loop
conform
prevent
transit
could
interfer
rest
amyloidogenesi
ham
strengthen
hypothesi
region
ham
adopt
conform
final
fibril
form
ham
use
peptid
inhibitor
typic
reli
sequenc
homologu
facilit
recognit
inhibitor
target
peptid
exampl
peptid
sequenc
similar
capabl
interact
amyloidogen
peptid
exampl
ghosh
et
al
demonstr
nine
residu
peptid
taken
sar
corona
viru
tabl
abl
inhibit
ham
amyloidogenesi
howev
worth
note
inhibitor
shown
capabl
aggreg
albeit
much
slower
rate
ham
main
drawback
approach
lack
univers
inhibitor
develop
inhibitor
deriv
optim
one
amyloidogen
peptid
effect
protein
repres
overli
specif
type
interact
howev
differ
approach
shown
effect
design
inhibitor
bear
sequenc
similar
target
peptid
approach
reli
design
stabl
prestructur
peptid
avail
edg
strand
capabl
bind
amyloidogen
peptid
bind
facilit
hydrophob
unit
edg
strand
inhibitor
favor
hydrophob
collaps
idea
trace
effort
smith
et
al
interest
build
upon
studi
found
antibodi
protein
capabl
recogn
solubl
oligom
varieti
amyloidogen
protein
initi
experi
involv
creat
phagedisplay
librari
would
allow
determin
random
mutant
templat
protein
capabl
interact
strongli
oligom
protein
implic
alzheim
diseas
found
mutant
contain
two
tyrosin
tyr
residu
substitut
two
tryptophan
trp
residu
substitut
suitabl
detect
target
kinet
assay
show
coincub
protein
result
complet
suppress
amyloidogenesi
huggin
et
al
expand
work
use
design
hairpin
peptid
contain
trp
andor
tyr
residu
expos
face
peptid
initi
studi
show
peptid
effect
inhibit
amyloidogenesi
ham
expand
studi
test
effect
inhibitor
second
amyloidogen
system
result
show
peptid
tabl
fig
abl
increas
lag
time
ham
amyloidogenesi
fold
coincub
molar
equival
concentr
fig
increment
concentr
inhibitor
increas
lag
time
ham
aggreg
hand
use
inhibitor
result
immedi
precipit
format
upon
addit
aggregatori
stimulu
hexafluoroisopropanol
hfip
precipit
shown
nonamyloid
aggreg
congo
red
stain
tem
studi
show
precipit
shorter
thicker
fibril
seen
amyloid
precipit
would
indic
peptid
slow
aggreg
ham
redirect
aggreg
offpathway
aggreg
peptid
also
test
ham
cell
result
show
ratio
ham
inhibitor
increas
cell
viabil
increas
dose
depend
seen
improv
concentr
inhibitor
increas
studi
huggin
et
al
brought
forth
interest
target
optim
peptid
tabl
fig
follow
new
set
aryl
rich
peptid
test
includ
cycliz
version
tabl
fig
done
test
hypothesi
fig
schemat
draw
show
secondari
structur
peptid
show
inhibit
cyclo
also
show
potenti
univers
amyloid
trap
sinc
also
show
activ
ham
stabil
inhibitor
would
play
role
increas
potenc
peptid
inhibitor
result
show
cycliz
definit
improv
potenc
approxim
inhibit
one
molar
equival
approxim
inhibit
coincub
presenc
ham
tabl
fig
show
even
stronger
inhibit
substoichiometr
concentr
abl
complet
inhibit
amyloidogenesi
ham
analyz
thioflavin
fluoresc
effect
inhibitor
also
test
cell
cytotox
assay
ratio
ham
enough
elimin
cytotox
ham
cell
nmr
analysi
also
perform
determin
inhibitor
bind
initi
experi
absenc
inhibitor
show
earliest
peak
attenu
occur
ntermin
section
particular
interest
fact
lot
peak
belong
hairpinregion
identifi
mirecka
et
al
part
earli
preamyloid
event
import
amyloidogenesi
one
last
portion
show
peak
attenu
ctermin
tail
correspond
region
remain
flexibl
solubl
oligom
phase
amyloidogenesi
therefor
quit
interest
main
bind
locu
locat
ctermin
tail
promin
bind
shift
observ
includ
fig
note
studi
done
ulrih
et
al
show
mutat
tyrosin
alanin
result
complet
inhibit
amyloidogenesi
therefor
possibl
residu
play
import
role
amyloid
format
possibl
long
rang
contact
part
peptid
notabl
shift
residu
within
found
undergo
phosphoryl
effect
phosphoryl
amyloidogenesi
unclear
initi
discoveri
phosphoryl
seem
indic
event
favor
amyloidogneesi
howev
second
studi
show
phosphoryl
result
increas
flexibl
region
lack
consensu
exactli
phosphoryl
seem
indic
play
signific
role
structur
function
tabl
fig
also
analyz
nmr
coincub
result
show
similar
bind
locu
ctermin
howev
secondari
bind
locu
identifi
residu
observ
shift
upon
titrat
note
region
correspond
hairpin
identifi
mirecka
et
al
taken
togeth
data
would
indic
region
play
import
earli
role
amyloid
format
studi
detail
sivanesam
et
al
also
show
inhibit
limit
type
adopt
potenti
peptid
inhibitor
turnless
made
dimer
connect
disulfid
bond
middl
test
inhibitor
amyloidogenesi
fig
result
show
equimolar
concentr
dimer
peptid
rwhchwe
capabl
inhibit
aggreg
increas
concentr
inhibitor
result
correspond
increas
amyloid
inhibit
studi
also
attempt
determin
presenc
phenol
would
impact
inhibit
peptid
small
peptid
contain
pair
tryptophan
tabl
compar
tyrosin
counterpart
kinet
assay
show
replac
trp
tyr
result
almost
fold
increas
percent
inhibit
result
support
previou
studi
shown
inhibit
strongli
phenol
compound
need
univers
inhibitor
amyloidogenesi
increas
link
amyloid
diseas
found
crossamyloid
interact
identifi
amyloidbeta
number
protein
includ
ham
clinic
studi
show
patient
suffer
type
ii
diabet
higher
risk
develop
alzheim
diseas
vice
versa
therefor
import
inhibitor
design
univers
futur
therapi
limit
one
target
protein
small
molecul
shown
abil
interact
multipl
amyloidogen
peptid
prevent
transit
toxic
oligom
phase
exampl
resveratrol
shown
inhibit
ham
vide
supra
congo
red
curcumin
shown
effect
protein
respons
alzheim
diseas
egcg
report
inhibitor
protein
addit
system
howev
focus
peptid
inhibitor
question
sequenc
similar
bind
motif
examin
far
investig
identifi
number
peptid
capabl
inhibit
amyloidogenesi
ham
bear
resembl
trpzip
peptid
vide
infra
effect
coincub
substoichiometr
concentr
either
ham
vivo
studi
peptid
ham
show
inhibitor
capabl
amelior
cytotox
ham
dosedepend
manner
display
sequenc
similar
amyloidogen
target
kapurniotu
cowork
also
demonstr
ham
interact
one
anoth
decreas
rate
amyloidogenesi
protein
studi
examin
whether
previous
test
ham
peptid
inhibitor
capabl
inhibit
amyloidogenesi
well
studi
show
coincub
equimolar
concentr
ham
inhibitor
capabl
prevent
cytotox
presenc
sinc
ham
inhibitor
test
fact
nmethyl
modifi
mimic
ham
residu
kapurniotu
cowork
studi
full
length
ham
abl
interact
result
show
coincub
peptid
exhibit
decreas
rate
amyloidogenesi
extens
follow
investig
show
region
within
region
within
ham
bind
strongli
one
anoth
term
region
hot
segment
within
peptid
build
upon
investig
inhibitor
deriv
link
hot
segment
ham
abl
inhibit
amyloidogenesi
either
protein
determin
link
hot
segment
would
abl
inhibit
amyloidogenesi
ham
nanomolar
concentr
make
one
potent
peptid
inihibitor
either
peptid
whether
extend
system
sequenc
homolog
yet
examin
evid
certain
inhibitor
capabl
inhibit
multipl
amyloidogen
peptid
daggett
cowork
investig
tryptophanzipp
peptid
trpzip
capabl
inhibit
amyloidogenesi
anoth
amyloidogen
peptid
transthyretin
ttr
studi
show
stabil
structur
trpzip
peptid
play
larg
role
abil
inhibit
amyloidogenesi
howev
presenc
expos
tryptophan
residu
import
interact
trpzip
ttr
sinc
mutant
trpzip
tryptophan
mutat
leucin
result
decreas
inhibit
strength
given
number
inhibitor
fig
ham
also
trprich
motif
expect
crossreact
found
futur
prestructur
peptid
avail
edg
strand
aryl
residu
capabl
bind
anoth
may
well
repres
class
univers
amyloid
trap
unfortun
none
recent
advanc
approach
point
becom
effect
therapi
method
deliveri
peptid
inhibitor
yet
discov
need
high
concentr
inhibitor
still
hurdl
inhibitor
studi
far
yield
interest
inform
amyloidogenesi
process
studi
inhibitor
bind
bind
affect
amyloid
pathway
lot
new
inform
uncov
amyloidogen
polypeptid
region
residu
increasingli
interest
possibl
preamyloid
secondari
structur
ham
possibl
loop
featur
form
residu
final
structur
fibril
could
import
target
area
studi
therefor
import
inhibitor
particular
univers
inhibitor
continu
studi
sinc
might
point
heretofor
unknown
similar
amyloid
protein
could
lead
develop
therapi
applic
amyloid
diseas
